Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis

FASEB Journal

Volumn 11, Issue 4, 1997, Pages 227-233

  Mundlos, S ^a,b   Olsen, B R ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

bone; chondrodysplasia; growth; growth plate; mutation; skeletal development

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; SCLEROPROTEIN;

ACHONDROPLASIA; ALBERS SCHOENBERG DISEASE; BONE DEVELOPMENT; BONE DYSPLASIA; BONE MATRIX; CARTILAGE MATRIX; CHONDRODYSPLASIA; EXTRACELLULAR MATRIX; GENE MUTATION; GROWTH PLATE; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SULFATION;

EID: 0030894287     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.4.9068611     Document Type: Review

References (73)

1. Mundlos, S. and Olsen, B. R. (1997) Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development - transcription factors and signalling pathways. FASEB J. 11, 125-132
2. Byers, P. (1993) Osteogenesis imperfecta. In Connective Tissue and its Heritable Disorders (Royce, P., Steinmann, B., eds) pp. 317-350, Wiley-Liss, New York
3. Willing, M. C., Deschenes, S. P., Slayton, R. L., and Roberts, E. J. (1996) Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am. J. Hum. Genet. 59, 799-809
4. Deak, S. B. M., Nicholls, A. F., Pope, F. M., and Prockop, D. J. (1983) The molecular defect in a nonlethal variant of osteogenesis imperfecta. J. Biol. Chem. 258, 15192-15197
5. Mundlos, S., Chan, D., Weng, Y.-M., Sillence, D. O., Cole, W. G., and Bateman, J. F. (1996) Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB: molecules containing the shortened α2(I)-chains show differential incorporation into the bone and skin extracellular matrix. J. Biol. Chem. 271, 21068-21074
6. Wang, Q., Orrison, B. M., and Marini, J. C. (1993) Two additional cases of osteogenesis imperfecta with substitutions for glycine in the α2(I) collagen chain. A regional model relating mutation location with phenotype. J. Biol. Chem. 268, 25162-25167
7. Bateman, J. F., Moeller, I., Hannagan, M., Chan, D., and Cole, W. G. (1992) Characterization of three osteogenesis imperfecta collagen α1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity. Biochem. J. 288, 131-135
8. Willing, M. C., Cohn, D. H., Starman, B., Holbrook, K. A., Greenberg, C. R., and Byers, P. H. (1988) Heterozygosity for a large deletion in the α2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal Osteogenesis imperfecta. J. Biol. Chem. 263, 8398-8404
9. Chu, M. L., Gargiulo, V., Williams, C. J., and Ramirez, F. (1985) Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA. J. Biol. Chem. 260, 691-694
10. Barsh, G. S., Roush, C. L., Bonadio, J., Byers, P. H., and Gelinas, R. E. (1985) Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 82, 2870-2874
11. Cohn, D. H., Zhang, X., and Byers, P. H. (1993) Homology-mediated recombination between type I collagen gene exons results in an internal tandem duplication and lethal osteogenesis imperfecta. Hum. Mutat. 2, 21-27
12. Byers, P. H., Wallis, G. A., and Willing, M. C. (1991) Osteogenesis imperfecta: translation of mutation to phenotype. J. Med. Genet. 28, 433-442
13. Wenstrup, R. J., Shrago-Howe, A. W., Lever, L. W., Phillips, C. L., Byers, P. H., and Cohn, D. H. (1991) The effects of different cysteine for glycine substitutions within alpha 2(1) chains. Evidence of distinct structural domains within the type I collagen triple helix. J. Biol. Chem. 266, 2590-2594
14. Bateman, J. F., and Golub, S. B. (1994) Deposition and selective degradation of structurally-abnormal type I collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. Matrix Biol. 14, 251-262
15. Schnieke, A., Harbers, K., and Jaenisch, R. (1983) Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. Nature (London) 304, 315-320
16. Stacey, A., Bateman, J., Choi, T., Mascara, T., Cole, W., and Jaenisch, R. (1988) Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature (London) 332, 131-136
17. Bonadio, J., Saunders, T. L., Tsai, E., Goldstein, S. A., Morris-Wiman, J., Brinkley, L., Dolan, D. F., Altschuler, R. A., Hawkins, J. E., Bateman, J. F., Mascara, T., and Jaenisch, R. (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 87, 7145-7149
18. Chipman, S. D., Sweet, H. O., McBride, D. J., Jr., Davisson, M. T., Marks, S. C. Jr., Shuldiner, A. R., Wenstrup, R. J., Rowe, D. W., and Shapiro, J. R. (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 90, 1701-1705
19. Pihlajaniemi, T., Dickson, L. A., Pope, F. M., Korhonen, V. R., Nicholls, A., Prockop, D. J., and Myers, J. C. (1984) Osteogenesis imperfecta: cloning of a proa2(I) collagen gene with a frameshift mutations. J. Biol. Chem. 259, 12941-13944
20. Spranger, J., Winterpacht, A., and Zabel, B. (1994) The type II collagenopathies: a spectrum of chondrodysplasias. Eur. J. Pediatr. 153, 56-65
21. Eyre, D. R., Upton, M. P., Shapiro, F. D., Wilkinson, R. H., and Vawter, G. F. (1986) Nonexpression of cartilage type II collagen in a case of Langer-Saldino achondrogenesis. Am. J. Hum. Genet. 39, 52-67
22. Chan, D., Cole, W. G., Chow, C. W., Mundlos, S., and Bateman, J. F. (1995) A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J. Biol. Chem. 270, 1747-1753
23. Mundlos, S., Chan, D., McGill, J., and Bateman, J. F. (1996) An α1(II) Gly to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. Am. J. Med. Genet. 63, 129-136
24. Sandell, L. J., Morris, N., Robbins, J. R., and Goldring, M. B. (1991) Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J. Cell Biol. 114, 1307-1319
25. Chea, K. S., Lau, E. T., Au, P. K., and Tam, P. P. (1991) Expression of the mouse α1(II) collagen gene is not restricted to cartilage during development. Development 111, 945-953
26. Chan, D., and Cole, W. G. (1991) Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells. Application to the characterization of a glycine 997 to serine substitution in alpha 1(II) collagen chains of a patient with spondyloepiphyseal dysplasia. J. Biol. Chem. 266, 2487-2494
27. Chan, D., Taylor, T. K., and Cole, W. G. (1993) Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. J. Biol. Chem. 268, 15238-15245
28. Winterpacht, A., Hilbert, M., Schwarze, U., Mundlos, S., Spranger, J., and Zabel, U. (1993) Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nature Genet. 3, 323-326
29. Zabel, B., Hilbert, K., Stöb, H., Superti-Furga, A., Spranger, J., and Winterpacht, A. (1996) A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia. Am. J. Med. Genet. 63, 123-128
30. Ahmad, N. N., Ala-Kokko, L., Knowlton, R. G., Jimenez, S. A., Weaver, E. J., Maguire, J. I., Tasman, W., and Prockop, D. J. (1991) Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc. Natl. Acad. Sci. USA 88, 6624-6627
31. Vandenberg, P., Khillan, J. S., Prockop, D. J., Helminen, H., Kontusaari, S., and Ala-kokko, L. (1991) Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc. Natl. Acad. Sci. USA 88, 7640-7644
32. Rintala, M., Metsäranta, M., Garofalo, S., de Crombrugghe, B., Vuorio, E., and Rönning, O. (1993) Abnormal craniofacial morphology and cartilage structure in transgenic mice harboring a Gly ⇒ Cys mutation in the cartilage-specific type II collagen gene. J. Craniofacial Genet. Dev. Biol. 13, 137-146
33. Pace, J. M., Li. Y., Seegmiller, R. E., Teuscher, C., Taylor, B. A., and Olsen, B. R. (1997) Disproportionate micromelia (Dmm) in mice caused by a mutation in the C-propeptide coding region of Col2a1. Dev. Dyn. 208, 25-33
34. Jacenko, O., Lu Valle, P. A., and Olsen, B. R. (1993) Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature (London) 365, 56-61
35. Warman, M. L., Abbott, M. H., Apte, S. S., Hefferon, T., McIntosh, I., Cohn, D. H., Hecht, J. T., Olsen, B. R., and Francomano, C. A. (1993) A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nature Genet. 5, 79-82
36. Chan, D., Cole, W. G., Rogers, J. G., and Bateman, J. F. (1995) Type X collagen multimer assembly in vitro is prevented by a Gly 618 to Val mutation in the alpha 1(X) NC1 domain resulting in Schmid metaphyseal chondrodysplasia. J. Biol. Chem. 270, 4558-4562
37. Rosati, R., Horan, G. S., Oinero, G. J., Garofalo, S., Keene, D. R., Horton, W. A., Vuorio, E., de Crombrugghe, B., and Behringer, R. R. (1994) Normal long bone growth and development in type X collagen-null mice. Nature Genet. 8, 129-135
38. Olsen, B. R. (1995) New insights into the function of collagens from genetic analysis. Curr. Opin. Cell Biol. 7, 720-727
39. Muragaki, Y., Mariman E. C. M., van Beersum, S. E. C., Perälä, M., van Mourik, J. B. A., Warman, M. L., Olsen, B. R., and Hamel, B. C. J. (1996) A mutation in the gene encoding the α2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nature Genet. 12, 103-105
40. Briggs, M. D., Choi, H., Warman, M. L., Loughlin, J. A., Wordsworth, P., Sykes, B. C., Irven, C. M., Smith, M., Wynne-Davies, R., Lipson, M. H., Biesecker, L. G., Garber, A. P., Lachman, R., Olsen, B. R., Rimoin, D. L., and Cohn, D. H. (1994) Genetic mapping of a locus for multiple epiphyseal dysplasia (EDM2) to a region of chromosome 1 containing a type IX collagen gene. Am. J. Hum. Genet. 55, 678-684
41. Nakata, K., Ono, K., Miyazaki, J.-I., Olsen, B. R., Muragaki, Y., Adachi, E., Yamamura, K.-I., and Kimura, T. (1993) Osteoarthritis associated with mild chondrodysplasia in transgenic mice expression α1(IX) collagen chains with a central deletion. Proc. Natl. Acad. Sci. USA 90, 2870-2874
42. Fässler, R., Schnegelsberg, P. N. J., Dausman, J., Shinya, T., Muragaki, Y., McCarthy, M. T., Olsen, B. R., and Jaenisch, R. (1994) Mice lacking α1(IX) collagen develop noninflammatory degenerative joint disease. Proc. Natl. Acad. Sci. USA 91, 5070-5074
43. Vikkula, M., Mariman, E. C. M., Lui, V. C. H., Zhidkova, N. I., Tiller, G. E., Goldring, M. B., van Beersum, S. E. C., de Waal Malefijt, M. C., van der Hoogen, F. H. J., Ropers, H.-H., Mayne, R., Cheah, K. S. E., Olsen, B. R., Warman, M. L., and Brunner, H. G. (1995) Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 80, 431-437
44. Mayne, R., Brewton, R. G., Mayne, P. M., and Baker, J. R. (1993) Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J. Biol. Chem. 268, 9381-9386
45. Li, Y., Lacerda, D. A., Warman, M. L., Beier, D. R., Yoshioka, H., Ninomiya, Y., Oxford, J. T., Morris, N. P., Andrikopoulos, K., Ramirez, F., Wardell, B. B., Lifferth, C. D., Teuscher, C., Woodwaed, S. R., Taylor, B. A., Seegmiller, R. E., and Olsen, B. R. (1995) A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 80, 423-430
46. Mundlos, S., Meyer, R., Yamada, Y., and Zahel, B. (1991) Distribution of cartilage proteoglycan core protein and link protein gene expression during human skeletal development. Matrix 11, 339-346
47. Watanabe, H., Kimata, K., Line, S., Strong, D., Gao,. L. Y,. kuzak, C. A., and Yamada, Y. (1994) Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nature Genet. 7, 54-157
48. Li, H., Schwartz, N. B., and Vertel, B. M. (1993) cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. J. Biol. Chem. 268, 23504-23511
49. Stanescu, V., Stanescu, R., and Maroteaux P. (1984) Pathogenic mechanisms in osteochondrodysplasias. J. Bone Joint Surg. 66A, 817-836
50. Briggs, M. D., Rasmussen, I. M., Weber, J. L., Yuen, J., Reinker, K., Garber, A. P., Rimoin, D. L., and Cohn, D. H. (1993) Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19. Genomics 18, 656-660
51. Hecht, J.T., Francomano, C. A., Briggs. M. D., Deere, M., Conner, B., Horton, W. A., Warman, M., Cohn, D. H., and Blanton, S. H. (1993) Linkage of typical pseudoachondroplasia to chromosome 19. Genomics 18, 661-666
52. Briggs, M. D., Hoffman, S. M. G., King, L. M., Olsen, A. S., Mohrenweiser, H., Leroy, J. G., Mortiier, G. R., Rimoin, D. L., Lachman, R. S., Gaines, E. S., Cekleniak, J. A., Knowlton, R. G., and Cohn, D. H. (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nature Genet. 10, 330-336
53. Hecht, J. T., Nelson, L. D., Crowder, E., Wang, Y., Elder, F. F. B., Harrison, W. R., Francomano, C. A., Prange, C. K., Lennon, G. G., Deere, M., and Lawler, J. (1995) Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondoplasia. Nature Genet. 10, 325-329
54. Stanescu, R., Stanescu, V., Muriel, M. P., and Maroteaux, P. (1993) Multiple epiphyseal dysplasia, Fairbank type: morphologic and biochemical study of cartilage. Am. J. Med. Genet. 45, 501-507
55. Oehlmann, R., Summerville, G. P., Yeh, G., Weaver, E. J., Jimenez, S. A., and Knowlton, R. G. (1994) Genetic linkage mapping of multiple epiphyseal dysplasia to the pericentromeric region of chromosome 19. Am. J. Hum. Genet. 54, 3-10
56. Deere, M., Blanton, S. H., Scott, C. I., Langer, L. O., Pauli, R. M., and Hecht, J. T. (1995) Genetic heterogeneity in multiple epiphyseal dysplasia. Am. J. Hum. Genet. 56, 698-704
57. Horton, W. A., Rimoin, D. L., Hollister, D. W., and Silberberg, R. (1979) Diastrophic dwarfism: a histochemical and ultrastructural study of the endochondral growth plate. Pediatr. Res. 13, 904-909
58. Hästbacka, J., de la Chapelle, A., Kaitila, , I., Sistonen, P., Weaver, A., and Lander, E. S. (1992) Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nature Genet. 2, 204-211
59. Hästbacka, J., de la Chapelle, A., Mahtani, M. M., Clines, G., Reeve-Daly, M. P., Daly, M., Hamilton, B. A., Kusumi, K., Trivedi, B., Weaver, A., Coloma, A., Lovett, M., Buckler, A., Kaitila, I., and Lander, E. S. (1994) The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 78, 1073-1087
60. Superti-Furga, A., Hästbacka, J., Wilcox, W. R., Cohn, D. H., van der Harten, H. J., Rossi, A., Blau, N., Rimoin, D. L., Steinmann, B., Lander, E. S., and Gitzelmann, R. (1996) Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nature Genet. 12, 100-102
61. Hästbacka, J., Wilcox, W. R., Superti-Furga, A., Rimoin, D. L., Cohn, D. H., and Lander, E. S. (1995) Atelosteogenesis type II is caused by mutations in the dystrophic dysplasia sulfate transporter gene (DTDST). Am. J. Mol. Genet. 57, A48
62. Pennypacker, J. P., Kimata, K., and Brown S. (1981) Brachymorphic mice (bm/bm); a generalized biochemical defect expressed primarily in cartilage. Dev. Biol. 81, 280-287
63. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702
64. Grigoriadis, A. E., Wang, Z. Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., and Wagner, E. F. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448
65. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W. J., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., and Stanley, E. R. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/ op) mouse. Proc. Natl. Acad. Sci. USA 87, 4828-4832
66. Gelb, B. D., Edelson, J. G., and Desnick, R. J. (1995) Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nature Genet. 10, 235-237
67. Gelb, B. D., Shi, G. P., Chapman, H. A., and Desnick, R. J. (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238
68. Morrison, N. A., Qi, J. C., Tokita, A., Kelley, P. J., Crofts, L., Nguyen, T. V., Sambrook, P. N., and Eisman, J. A. (1994) Prediction of bone density from vitamin D receptor alleles. Nature (London) 367, 284-287
69. Hustmyer, F. G., Peacock, M., Hui, S., Johnston, C. C., and Christian, J. (1994) Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J. Clin. Invest. 94, 2130-2134
70. Lim, S. K., Park, Y. S., Park, J. M., Song, Y. D., Lee, E. J., Kim, K. R., Lee, H. C., and Huh, K. B. (1995) Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J. Clin. Endocrinol. Metab. 80, 3677-3681
71. Houston, L. A., Grant, S. F., Reid, D. M., and Ralston, S. H. (1996) Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone 18, 249-252
72. Garnero, P., Borel, O., Sornay-Rendu, E., Ariot, M. E., and Delmas, P. D. (1996) Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY study. J. Bone Miner. Res. 11, 827-834
73. Gong, Y., Vikkula, M., Boon, L., Liu, J., Beighton, P., Ramesar, R., Peltonen, L., Somer, H., Hirose, T., Dallapiccola, B., De Paepe, A., Swoboda, W., Zabel, B., Superti-Furga, A., Steinmann, B., Brunner, H. G., Jans, A., Boles, R. G., Adkins, W., van der Boogaard, M. J., Olsen, B. R., and Warman, M. L. (1996) Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am. J. Hum. Genet. 59, 146-151